| Name
|
Adeno-Associated Virus Epitope 2 (AAV2)
|
| Code
|
|
| The alias
|
Adeno-Associated Virus Epitope 2 (AAV2)
|
| Sequence (single letter abbreviation)
|
VPQYGYLTL
|
| Sequence (three-letter abbreviation)
|
H-Val-Pro-Gln-Tyr-Gly-Tyr-Leu-Thr-Leu-OH (trifluoroacetate salt)
|
| A basic description
|
Inhibitor of human matrix metalloproteinases that maintains its activity even after prolonging incubation with pronase or human granulocyte elastase. It also inhibits interstitial and granulocyte collagenases, granulocyte gelatinase and skin fibroblast stromelysin with IC50 of 1 x 10-6?M, 3 x 10-5?M and 1.5 x 10-4?M, respectively.
|
| solubility
|
|
| The molecular weight
|
1053.2
|
| Chemical formula
|
C51H76N10O14
|
| The purity
|
80%，90%，95%，98%，99%
|
| Weight
|
1mg,5mg,10mg,50mg,100mg,1g
|
| Storage conditions
|
Store at -20°C. Keep tightly closed. Store in a cool dry place.
|
| Annotation
|
|
| Documents
|
|
| Figures
|
|
| Reference
|
Murphy, S. et al. Blood (ASH Annual Meeting Abstracts), 108 (2006)
Mingozzi, F. et al. Nature Medicine 10.1038/nm1549 (2007)
Wang, L. et al. Therapy. 18, 185 (2007)
|
| The C-terminal
|
|
| The N-terminal
|
|
| Chemical bridge
|
|